In- Vitro Toxicology Testing Market Introduction and Overview
According to SPER Market Research, the Global In-Vitro Toxicology Testing Market is estimated to reach USD 34.76 billion by 2033 with a CAGR of 11.05%.
The report includes an in-depth analysis of the Global In-Vitro Toxicology Testing Market, including market size and trends, product mix, applications, and supplier analysis. Experiments employing separated body tissues, organs, or cells are referred to as in vitro toxicity testing. By monitoring the impact of chemicals on these biological systems, these experiments seek to understand their toxicity. In the early stages of product development, the main goals are to find safe exposure thresholds, identify potentially harmful effects, and screen for side effects. Cell-Based Assays, these testing methods evaluate the cellular reactions of harmful chemicals by use of cultivated cell lines. Second are Tissue-Based Assays, which assess a substance's effects on certain tissues or organs using tissue cultures or explants. Organ-on-Chip Models, these sophisticated models imitate human organ functioning on microchips, enabling more intricate and precise toxicity calculations.
- September 2019; In an effort to expand its in-vitro toxicology testing business throughout Asia Pacific, Covance, based in Shanghai, opened a new R&D facility in China.
- August 2019; Abbott established a partnership with Intoximeters to market the SoToxa Mobile Test System, a portable oral fluid solution for drug and alcohol testing, in the US. Amphetamine, benzodiazepines, cocaine, methamphetamine, opiates, and cannabis (THC) can all be detected by the device.
- August 2019; Covance expanded their functional vendor (FSPx) offering to include clinical analytics services, clinical operations capabilities, and an analytical laboratory component.
Market Opportunities and Challenges
Opportunities- Continuous advancements in toxicological research and technological advancements are credited with the market's growth. Further projected to support the market is the growing emphasis on the creation of customized medications. People are becoming more and more aware of the drawbacks and difficulties of using conventional toxicological screening techniques. Because of this, in-vitro testing is now more widely recognized as a useful method for determining the safety and effectiveness of different chemicals. In vitro and alternative testing procedures have seen a substantial increase in validation and adoption by regulatory bodies in recent times. Increased usage of in vitro screening and monitoring models has resulted from ongoing technological developments aimed at replacing animal testing in toxicology.
Challenges- For in vitro testing to be considered a valid alternative to or supplement to animal testing, it must be approved by numerous regulatory bodies. This can be a drawn-out and difficult procedure. Standardized protocols are necessary to guarantee uniformity in testing methods and outcomes throughout various labs and research projects. The intricacy of human physiology, which includes metabolism, immunological responses, and interactions among multiple organs, is frequently not accurately reflected in in vitro models. This reduces their ability to accurately forecast how chemicals would affect entire species. The significance of the results may be impacted if commonly utilized cell lines do not adequately represent human tissue types or situations.
Market Competitive Landscape
The global In-vitro Toxicology Testing industry is home to several major players, including GE Healthcare, Quest Diagnostics Incorporated, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, Abbott, Merck KGaA, Charles River, Bio-Rad Laboratories, Inc, Quest Diagnostics Incorporated, Catalent, Inc, AGILENT TECHNOLOGIES.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Method, By End Use, By Technology, By Application
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Abbott, Agilent Technologies, BioIVT, Bio-Rad Laboratories, Inc, Catalent, Inc, Charles River, Creative Bioarray, Evotec, Eurofins Scientific, GE Healthcare, Gentronix, Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, SGS SA, Thermo Fisher Scientific Inc.
|
COVID-19 Impact on Global In- Vitro Toxicology Testing Market
The market for in vitro toxicity tests has been significantly impacted by the COVID-19 epidemic. Due to the pandemic's disruption, there were shortages of necessary supplies and reagents for in vitro toxicity testing. This affected the laboratories' capacity to perform tests and satisfy requests. Timelines for testing and research were impacted by delays in the supply of essential supplies and equipment caused by restrictions and lockdowns. Research funds and priorities were redirected toward COVID-19-related research, vaccine development, and antiviral medications because to the pressing need to fight the pandemic. As a result, non-COVID-related toxicology research received less funding and attention than other fields.
Key Target Audience:
- Contract Research Organizations (CROs)
- Regulatory Agencies
- Academic and Research Institutions
- Chemical and Cosmetic Companies
- Healthcare and Medical Device Companies
- Environmental and Consumer Safety Organizations
- Insurance and Risk Management Firms
- Regulatory Consultants and Advisors
- Investors and Venture Capitalists
Our in-depth analysis of the Global In- Vitro Toxicology Testing Market includes the following segments:
| By Method: | Cellular AssayLive CellsFixed CellsBiochemical AssayIn-SilicoEx-vivo |
| By End Use: | Pharmaceutical IndustryCosmetics & Household ProductsAcademic Institutes and Research LaboratoriesDiagnosticsChemical IndustryFood Industry |
| By Technology: | Cell Culture TechnologyHigh Throughput TechnologyMolecular ImagingOMICS Technology |
| By Application: | Systemic ToxicologyDermal ToxicityEndocrine DisruptionOcular ToxicityOther Applications |
Key Topics Covered in the Report:
- Global In-Vitro Toxicology Testing Market Size (FY’2024-FY’2033)
- Overview of Global In-Vitro Toxicology Testing Market
- Segmentation of Global In-Vitro Toxicology Testing Market by Method (Cellular Assay {Live Cells, Fixed Cells}, Biochemical Assay, in-Silico, Ex- Vivo)
- Segmentation of Global In-Vitro Toxicology Testing Market by End-Use (Pharmaceutical Industry, Cosmetics and Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemical Industry, Food industry)
- Segmentation of Global In-Vitro Toxicology Testing Market by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology)
- Segmentation of Global In-Vitro Toxicology Testing Market by Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruptions, Ocular Toxicity, Other Applications)
- Statistical Snap of Global In-Vitro Toxicology Testing Market
- Expansion Analysis of Global In-Vitro Toxicology Testing Market
- Problems and Obstacles in Global In-Vitro Toxicology Testing Market
- Competitive Landscape in the Global In-Vitro Toxicology Testing Market
- Impact of COVID-19 and Demonetization on Global In-Vitro Toxicology Testing Market
- Details on Current Investment in Global In-Vitro Toxicology Testing Market
- Competitive Analysis of Global In-Vitro Toxicology Testing Market
- Prominent Players in the Global In-Vitro Toxicology Testing Market
- SWOT Analysis of Global In-Vitro Toxicology Testing Market
- Global In-Vitro Toxicology Testing Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global In-Vitro Toxicology Testing Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global In-Vitro Toxicology Testing Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global In-Vitro Toxicology Testing Market
7. Global In-Vitro Toxicology Testing Market, By Method (USD Million) 2020-2033
7.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2020-2026
7.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2027-2033
7.3. Cellular Assay
7.3.1. Live Cells
7.3.2. Fixed Cells
7.4. Biochemical Assay
7.5. In-Silico
7.6. Ex-vivo
8. Global In-Vitro Toxicology Testing Market, By End Use (USD Million) 2020-2033
8.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2020-2026
8.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2027-2033
8.3. Pharmaceutical Industry
8.4. Cosmetics & Household Products
8.5. Academic Institutes and Research Laboratories
8.6. Diagnostics
8.7. Chemical Industry
8.8. Food Industry
9. Global In-Vitro Toxicology Testing Market, By Technology (USD Million) 2020-2033
9.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2020-2026
9.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2027-2033
9.3. Cell Culture Technology
9.4. High Throughput Technology
9.5. Molecular Imaging
9.6. OMICS Technology
10. Global In-Vitro Toxicology Testing Market, By Application (USD Million) 2020-2033
10.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application, 2020-2026
10.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application 2027-2033
10.3. Systemic Toxicology
10.4. Dermal Toxicity
10.5. Endocrine Disruption
10.6. Ocular Toxicity
10.7. Other Applications
11. Global In-Vitro Toxicology Testing Market Forecast, 2020-2033 (USD Million)
11.1. Global In-Vitro Toxicology Testing Market Size and Market Share
12. Global In-Vitro Toxicology Testing Market, By Region, 2020-2033 (USD Million)
12.1. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2020-2026)
12.2. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2027-2033)
12.3. Asia-Pacific
12.3.1. Australia
12.3.2. China
12.3.3. India
12.3.4. Japan
12.3.5. South Korea
12.3.6. Rest of Asia-Pacific
12.4. Europe
12.4.1. France
12.4.2. Germany
12.4.3. Italy
12.4.4. Spain
12.4.5. United Kingdom
12.4.6. Rest of Europe
12.5. Middle East and Africa
12.5.1. Kingdom of Saudi Arabia
12.5.2. United Arab Emirates
12.5.3. Qatar
12.5.4. South Africa
12.5.5. Egypt
12.5.6. Morocco
12.5.7. Nigeria
12.5.8. Rest of Middle-East and Africa
12.6. North America
12.6.1. Canada
12.6.2. Mexico
12.6.3. United States
12.7. Latin America
12.7.1. Argentina
12.7.2. Brazil
12.7.3. Rest of Latin America
13. Company Profile
13.1. ABBOTT
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. AGILENT TECHNOLOGIES
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. BIO-RAD LABORATORIES, INC
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. CATALENT, INC
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. EUROFINS SCIENTIFIC
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. GE HEALTHCARE
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. MERCK KGAA
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. QUEST DIAGNOSTICS INCORPORATED
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. THERMO FISHER SCIENTIFIC INC
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
